不同临床场景下黑色素瘤诊断需治疗人数Meta分析
该Meta分析纳入29项观察性研究、共398,549例活检或切除,比较不同临床场景下黑色素瘤诊断的需治疗人数(NNT)。总体NNT为9.71(95%CI 7.72-12.29),初级保健为22.62、皮肤科为9.60、色素性病变专家为5.85,提示专科参与可改善患者结局。
要点
- 总体黑色素瘤诊断NNT为9.71,即约每10例活检发现1例黑色素瘤。
- 色素性病变专家NNT最低(5.85),皮肤科居中(9.60),初级保健最高(22.62)。
- 涉及专科医生诊断色素性皮肤病变可能改善患者结局。
核心结论
- 色素性病变专家的NNT最低,其次是皮肤科医生,提示专科参与色素性皮肤病变的诊断和治疗可能改善患者结局。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE中所有关于黑色素瘤NNT的相关观察性研究,采用随机效应模型合并NNT并报告95%CI,按临床场景进行亚组分析。
- 共纳入29篇文章,合计398,549例活检/切除。
主要发现
- 总体NNT为9.71(95%CI 7.72-12.29)。
- 初级保健NNT为22.62(95%CI 12.95-40.10)。
- 皮肤科NNT为9.60(95%CI 6.97-13.41)。
- 色素性病变专家NNT为5.85(95%CI 4.24-8.27)。
临床怎么用
- 在色素性皮肤病变的诊断中,可参考不同临床场景的NNT评估活检效率,优先考虑皮肤科或色素性病变专科评估。
局限性
- 数据报告存在异质性,且可能遗漏研究。
- 不同临床场景的黑色素瘤发病率不同,可能影响NNT计算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide a formal statistical comparison of the efficacy of melanoma detection among different clinical settings. METHODS: A systematic review and meta-analysis of all relevant observational studies on number needed to treat (NNT) in relation to melanoma was performed in MEDLINE. We performed a random-effects model meta-analysis and reported NNTs with 95% confidence intervals (CIs). The subgroup analysis was related to clinical setting. RESULTS: In all, 29 articles including a total of 398,549 biopsies/excisions were analyzed. The overall NNT was 9.71 (95% CI, 7.72-12.29): 22.62 (95% CI, 12.95-40.10) for primary care, 9.60 (95% CI, 6.97-13.41) for dermatology, and 5.85 (95% CI, 4.24-8.27) for pigmented lesion specialists. LIMITATIONS: There is heterogeneity in data reporting and the possibility of missing studies. In addition, the incidence of melanoma varies among clinical settings, which could affect NNT calculations. CONCLUSION: Pigmented lesion specialists have the lowest NNT, followed by dermatologists, suggesting that involving specialists in the diagnosis and treatment of pigmented skin lesions can likely improve patient outcomes.
引用
- Petty AJ, Ackerson B, Garza R, et al. Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting. J Am Acad Dermatol. 2020. PMID: 31931085. doi:10.1016/j.jaad.2019.12.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。